Profil
Rajinder Singh worked as Vice President-Chemistry at Rigel Pharmaceuticals, Inc. from 1998 to 2016.
He then worked as Senior Vice President-Research at ChemoCentryx, Inc. from 2016 to 2019.
Singh holds a doctorate degree from the University of Oxford.
Anciens postes connus de Rajinder Singh
| Sociétés | Poste | Fin |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 |
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | - |
Formation de Rajinder Singh
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
